PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis- 5 Year Results from an Open Label Extension Study
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1422
https://www.valueinhealthjournal.com/article/S1098-3015(12)03135-X/fulltext
Title :
PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis- 5 Year Results from an Open Label Extension Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03135-X&doi=10.1016/j.jval.2012.08.1422
First page :
A451
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
919